Finally, please explain the CRF’s policies for accepting industry funding by answering the following questions. For each question, please respond by first repeating the enumerated question followed by the appropriate answer.
1.
Please describe the policies for accepting industry funding and whether or not the CRF allows companies to place restrictions or provide guidance on how funding will be spent.
2.
If the CRF allows companies to place restrictions on industry funding, then please explain all restrictions and/or guidance for each transfer of value from a pharmaceutical company since January 1, 2003. For every transfer of value with a restriction, please provide the following information: year of transfer, name of company, and restriction placed on funding.
3.
Please provide the CV’s and financial disclosures filed with the CRF by all senior officials and members of the CRF board.
4.
Please provide all communications between the CRF and representatives of the following companies. The time span of this request covers January 1, 2007 to the present.
a.
Abbott Laboratories;
b.
Medtronic Inc.;
c.
Medinol;
d.
Boston Scientific; and
e.
Johnson & Johnson.
In cooperating with the Committees’ review, no documents, records, data or information related to these matters shall be destroyed, modified, removed or otherwise made inaccessible to the Committees.
We look forward to hearing from you by no later than October 30, 2008.
Sincerely,
Herb Kohl Charles E. Grassley
Chairman Ranking Member
Special Committee on Aging Committee on Finance